ACXP logo

Acurx Pharmaceuticals, Inc. (ACXP)

Profile

Full Name

Acurx Pharmaceuticals, Inc.

Ticker

NASDAQ: ACXP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 25, 2021

Indexes

Not included

Website

https://www.acurxpharma.com

Employees

4

Key Details

Price

$4.62(-3.14%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$17.40(-1413.04% YoY)

PE ratio

-

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.62
    ACXP price is $4.62

    30-Day Relative Volume

    1.16
    ACXP 30-day relative volume is 1.16

    Price Performance

    Price Most recent change

    -3.14%
    ACXP price was down -3.14% on Aug 29, 2025

    Price YTD change

    -71.62%
    ACXP price is down -71.62% since January 1st

    Price 1-year change

    -89.55%
    ACXP price is down -89.55% year-on-year

    Price 3-year change

    -93.21%
    ACXP price is down -93.21% over the past 3 years

    Price Range

    Price All-time high

    $176.40
    ACXP price is currently -97.38% below its historical high of $176.40

    Price 3-year low

    $3.80
    ACXP price is currently +21.58% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $7.11M
    ACXP market capitalization is $7.11 million

    Market cap 3-year change

    -81.7%
    ACXP market capitalization is down -81.7% over the past 3 years

    Market cap All-time high

    $79.30M
    ACXP market capitalization is currently -91.04% below its historical high of $79.30 million

    Market cap sector rank

    12.94%
    ACXP market capitalization is higher than 12.94% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +89.36%
    ACXP shares outstanding is up +89.36% year-on-year

    Shares Outstanding 3-Year Change

    +169.34%
    ACXP shares outstanding is up +169.34% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.70
    ACXP beta is 0.70

    200-day SMA

    $11.95
    ACXP price is currently -61.34% below its 200-day simple moving average

    50-day SMA

    $7.48
    ACXP price is currently -38.24% below its 50-day simple moving average

    RSI

    36.09
    ACXP 14-day relative strength index is 36.09

    Volume

    1.16
    ACXP 30-day relative volume is 1.16

    ATR

    $0.81
    ACXP average true range is $0.81

    10-day Historical Volatility

    92.47%
    ACXP 10-day historical volatility is 92.47%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ACXP annual revenue is $0.00

    Revenue Analysts estimate

    -
    ACXP annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    ACXP annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.64%
    ACXP annual revenue is higher than 28.64% of companies in Healthcare sector

    EPS

    EPS

    -$17.40
    ACXP annual earnings per share is -$17.40

    EPS Analysts estimate

    -$6.54
    ACXP annual earnings per share is currently +165.85% higher than the consensus analysts' forecast

    EPS 1-year change

    -1413.04%
    ACXP annual earnings per share is down -1413.04% year-on-year

    EPS Sector rank

    8.64%
    ACXP annual earnings per share is higher than 8.64% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    ACXP annual gross profit is $0.00

    Gross margin

    -
    ACXP annual gross profit margin value is unknown

    Operating profit

    -$14.10M
    ACXP annual operating income is -$14.10 million

    Operating margin

    -
    ACXP annual operating profit margin value is unknown

    Net income

    -$14.10M
    ACXP annual net profit is -$14.10 million

    Net margin

    -
    ACXP annual net profit margin value is unknown

    Expenses

    Total expenses

    $14.10M
    ACXP annual total expenses is $14.10 million

    Operating expenses

    $14.10M
    ACXP annual total operating expenses is $14.10 million

    Cost of goods sold

    $0.00
    ACXP annual cost of goods sold is $0.00

    Selling, general & administrative expenses

    $8.70M
    ACXP annual SGA is $8.70 million

    Depreciation and amortization

    -
    ACXP annual depreciation & amortization value is unknown

    Interest expense

    $0.00
    ACXP annual interest expense is $0.00

    Income tax

    $0.00
    ACXP annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$14.10M
    ACXP annual earnings before interest & taxes is -$14.10 million

    EBITDA

    -$14.10M
    ACXP annual EBITDA is -$14.10 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $3.86M
    ACXP annual total assets is $3.86 million

    Non current assets

    $0.00
    ACXP annual long term assets is $0.00

    Current assets

    $3.86M
    ACXP annual total current assets is $3.86 million

    Cash and cash equivalents

    $3.71M
    ACXP annual cash & cash equivalents is $3.71 million

    Accounts receivable

    -
    ACXP annual accounts receivable value is unknown

    Inventory

    $0.00
    ACXP annual inventory is $0.00

    Liabilities

    Total liabilities

    $3.24M
    ACXP annual total liabilities is $3.24 million

    Long term liabilities

    $0.00
    ACXP annual total long term liabilities is $0.00

    Current liabilities

    $3.24M
    ACXP annual total current liabilities is $3.24 million

    Accounts payable

    $0.00
    ACXP annual accounts payable is $0.00

    Debt

    Total debt

    $0.00
    ACXP annual total debt is $0.00

    Total debt 1-year change

    0%
    ACXP annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    ACXP annual long term debt is $0.00

    Short term debt

    $0.00
    ACXP annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $615.10K
    ACXP annual stockholders equity is $615.10 thousand

    Book value

    $615.10K
    ACXP annual book value is $615.10 thousand

    Retained earnings

    -$67.32M
    ACXP annual retained earnings is -$67.32 million

    Working capital

    $615.20K
    ACXP annual working capital is $615.20 thousand

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$10.38M
    ACXP annual cash flow from operations is -$10.38 million

    Cash from operations 1-year change

    -5.94%
    ACXP annual cash flow from operations is down -5.94% year-on-year

    Cash from investing

    $0.00
    ACXP annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    0%
    ACXP annual cash flow from investing activities has remained unchanged year-on-year

    Cash from financing

    $6.62M
    ACXP annual cash flow from financing activities is $6.62 million

    Cash from financing 1-year change

    -18.95%
    ACXP annual cash flow from financing activities is down -18.95% year-on-year

    CAPEX

    CAPEX

    $0.00
    ACXP annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    ACXP annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$10.38M
    ACXP annual free cash flow is -$10.38 million

    Free cash flow 1-year change

    -5.94%
    ACXP annual free cash flow is down -5.94% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ACXP annual gross profit margin value is unknown

    Operating margin

    -
    ACXP annual operating profit margin value is unknown

    Net margin

    -
    ACXP annual net profit margin value is unknown

    ROA & ROE

    ROA

    -243.85%
    ACXP annual return on assets is -243.85%

    ROE

    -534.03%
    ACXP annual return on equity is -534.03%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ACXP price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ACXP price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.99
    ACXP price to book ratio is 1.99

    PB ratio Sector rank

    53.95%
    ACXP price to book ratio is higher than 53.95% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ACXP price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ACXP price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.04M
    ACXP enterprise value is $1.04 million

    Enterprise value Sector rank

    13.76%
    ACXP enterprise value is higher than 13.76% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.10
    ACXP EV/EBITDA is -0.10

    EV/EBITDA Sector rank

    60.97%
    ACXP EV/EBITDA is higher than 60.97% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.19
    ACXP annual current ratio is 1.19

    Quick ratio

    1.19
    ACXP annual quick ratio is 1.19

    Leverage

    Debt to equity

    0.00
    ACXP annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ACXP annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ACXP piotroski f-score value is unknown

    Altman Z-Score

    -34.99
    ACXP altman z-score is -34.99

    Analyst ratings

    Recent major analysts updates

    Aug 12, 25 HC Wainwright & Co.
    Buy
    Mar 19, 25 HC Wainwright & Co.
    Buy
    Jan 13, 25 HC Wainwright & Co.
    Buy
    Jan 10, 25 HC Wainwright & Co.
    Buy
    Dec 10, 24 HC Wainwright & Co.
    Buy
    Nov 14, 24 HC Wainwright & Co.
    Buy
    Aug 12, 24 HC Wainwright & Co.
    Buy
    May 16, 24 HC Wainwright & Co.
    Buy
    Mar 19, 24 HC Wainwright & Co.
    Buy
    Feb 28, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with ACXP included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Acurx Pharmaceuticals, Inc.?
    • Does Acurx Pharmaceuticals, Inc. pay dividends?
    • What sector is Acurx Pharmaceuticals, Inc. in?
    • What industry is Acurx Pharmaceuticals, Inc. in?
    • What country is Acurx Pharmaceuticals, Inc. based in?
    • When did Acurx Pharmaceuticals, Inc. go public?
    • Is Acurx Pharmaceuticals, Inc. in the S&P 500?
    • Is Acurx Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Acurx Pharmaceuticals, Inc. in the Dow Jones?
    • When was Acurx Pharmaceuticals, Inc.'s last earnings report?
    • When does Acurx Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Acurx Pharmaceuticals, Inc.?

    The ticker symbol for Acurx Pharmaceuticals, Inc. is NASDAQ:ACXP

    Does Acurx Pharmaceuticals, Inc. pay dividends?

    No, Acurx Pharmaceuticals, Inc. does not pay dividends

    What sector is Acurx Pharmaceuticals, Inc. in?

    Acurx Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Acurx Pharmaceuticals, Inc. in?

    Acurx Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Acurx Pharmaceuticals, Inc. based in?

    Acurx Pharmaceuticals, Inc. is headquartered in United States

    When did Acurx Pharmaceuticals, Inc. go public?

    Acurx Pharmaceuticals, Inc.'s initial public offering (IPO) was on June 25, 2021

    Is Acurx Pharmaceuticals, Inc. in the S&P 500?

    No, Acurx Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Acurx Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Acurx Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Acurx Pharmaceuticals, Inc. in the Dow Jones?

    No, Acurx Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Acurx Pharmaceuticals, Inc.'s last earnings report?

    Acurx Pharmaceuticals, Inc.'s most recent earnings report was on August 12, 2025

    When does Acurx Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Acurx Pharmaceuticals, Inc. is November 13, 2025
    On this page